Doctors Note Logo

Published on: 5/21/2026

Understanding Dulera Dosages for Severe Persistent Asthma: Doctor Metrics

Dulera is a combination inhaler containing mometasone furoate (a corticosteroid) and formoterol fumarate (a long-acting beta-agonist) used to treat severe persistent asthma in patients 12 years and older. It works by reducing airway inflammation and relaxing airway muscles to improve breathing. The typical high-dose regimen is 2 inhalations of the 200 mcg/5 mcg strength twice daily. Doctors personalize dosing using lung function tests, symptom tracking, and side effect monitoring to optimize respiratory outcomes.

Key factors such as proper inhaler technique, tapering schedules, lifestyle adjustments, and ongoing side effect monitoring can significantly impact your treatment success.

If you're experiencing asthma symptoms or unsure whether your current treatment is working, taking a free, instant, online symptom check can help you better understand what's going on and guide your next steps. It's a fast, AI-powered tool trusted by millions—no signup required—that can help you clarify concerns before your next doctor visit and make more informed decisions about your respiratory health.

Reviewed for medical accuracy: 07/03/2026

answer background

Explanation

Understanding Dulera Dosages for Severe Persistent Asthma: Doctor Metrics

Severe persistent asthma requires both powerful anti-inflammatory control and reliable bronchodilation. Dulera combines an inhaled corticosteroid (mometasone furoate) with a long-acting beta₂-agonist (formoterol fumarate). Getting the dulera dosage for severe persistent asthma right can improve lung function, reduce exacerbations, and help you breathe easier.

What Is Dulera and How Does It Work?

Dulera is a combination inhaler that delivers:

  • Mometasone furoate (an inhaled corticosteroid or ICS) to reduce airway inflammation.
  • Formoterol fumarate (a long-acting beta₂-agonist or LABA) to relax the muscles around the airways.

Together, they target both the underlying inflammation and the bronchospasm that characterize severe persistent asthma.

Indications for Severe Persistent Asthma

Dulera is approved for patients aged 12 years and older with asthma not adequately controlled on a low- to medium-dose ICS alone. It's particularly useful when:

  • You have frequent daytime symptoms (more than twice per week).
  • Nighttime awakenings occur frequently (more than twice per month).
  • You need quick-relief inhalers daily.
  • Asthma exacerbations are common (two or more per year requiring oral steroids).

When symptoms persist despite other therapies, your doctor may prescribe a higher dulera dosage for severe persistent asthma.

Standard Dulera Dosage Regimens

Dulera comes in two strengths:

  • 100 mcg mometasone / 5 mcg formoterol per inhalation
  • 200 mcg mometasone / 5 mcg formoterol per inhalation

Dosage is expressed as "inhalations per dose, twice daily." Here's how doctors typically structure it:

Dosage Strength Low-Dose Regimen Medium-Dose Regimen High-Dose Regimen
100 / 5 1 inhalation twice daily 2 inhalations once daily or 1 inhalation twice daily Not commonly used
200 / 5 Not routinely used 1 inhalation twice daily 2 inhalations twice daily (max)

For severe persistent asthma, the usual high-dose regimen is:

  • 2 inhalations of 200 mcg/5 mcg twice daily
    – Total mometasone = 800 mcg/day
    – Total formoterol = 20 mcg/day

Always start at the lowest effective dose and increase only under medical supervision.

Doctor Metrics: How Your Physician Monitors Therapy

Your doctor will use several key metrics to ensure your dulera dosage for severe persistent asthma is optimized:

  • Lung Function Tests
    • Spirometry (FEV₁, FVC) every 3–6 months
    • Peak expiratory flow (daily home monitoring)
  • Symptom Tracking
    • Frequency of daytime and nighttime symptoms
    • Rescue inhaler (short-acting beta₂-agonist) use
  • Exacerbation History
    • Oral corticosteroid courses in the past year
    • Emergency visits or hospitalizations
  • Side Effects Assessment
    • Local: oral thrush, hoarseness
    • Systemic (rare at recommended doses): adrenal suppression, bone density changes
  • Patient-Reported Outcomes
    • Quality of life questionnaires (e.g., Asthma Control Test)

Regular follow-up (every 1–3 months initially) helps your doctor adjust dosing and address any concerns.

Key Points on Administration and Technique

Proper inhaler technique is crucial. Follow these steps:

  1. Shake the inhaler well.
  2. Breathe out fully.
  3. Place the mouthpiece between your lips and seal well.
  4. Press down once and inhale slowly and deeply.
  5. Hold breath for 5–10 seconds.
  6. Wait about 1 minute before a second inhalation.
  7. Rinse mouth with water and spit out to reduce thrush risk.

Potential Side Effects and Warnings

While Dulera is generally well tolerated, be aware of:

  • Common side effects:
    • Throat irritation
    • Hoarseness
    • Oral yeast infection (thrush)
  • Less common/systemic:
    • Adrenal insufficiency (if abruptly stopped)
    • Decreased bone mineral density (with long-term high-dose)
  • Serious reactions (rare):
    • Paradoxical bronchospasm (wheezing right after use)
    • Immediate hypersensitivity

If you experience severe chest pain, vision changes, or signs of adrenal crisis (e.g., fatigue, dizziness), speak to a doctor immediately.

Adjusting and Stepping Down Therapy

Once asthma is controlled for at least 3 months—with normal lung function and no exacerbations—your doctor may:

  • Reduce to medium dose (e.g., 1 inhalation of 200/5 twice daily).
  • Switch to the lowest effective strength (e.g., 100/5).
  • Monitor closely to catch any worsening.

Never stop Dulera abruptly; taper under medical supervision to avoid rebound inflammation.

Lifestyle and Supportive Strategies

Medication is just one part of asthma control. Complement Dulera therapy with:

  • Trigger avoidance (allergens, smoke, pollution)
  • Regular exercise with proper warm-up
  • Weight management
  • Stress reduction techniques
  • Influenza and pneumococcal vaccinations

If you're experiencing new or worsening respiratory symptoms, take Ubie's free AI-powered symptom checker to get personalized insights about your condition and determine whether you should seek medical attention.

When to Contact Your Doctor

Even with optimal dosing, severe persistent asthma can flare. Call your healthcare provider if you notice:

  • Rapidly worsening symptoms or peak flow readings
  • Need for rescue inhaler more than 4 times per day
  • Awakening at night with asthma symptoms
  • Confusion, inability to speak full sentences, or bluish lips
  • New or unusual side effects

For any life-threatening signs—severe breathlessness at rest, confusion, or loss of consciousness—seek emergency help right away.

Summary

  • Dulera combines mometasone (ICS) and formoterol (LABA) in a single inhaler.
  • dulera dosage for severe persistent asthma often starts at 2 inhalations of the 200 mcg/5 mcg strength twice daily (max).
  • Your doctor uses lung function tests, symptom tracking, and side-effect monitoring to guide dose adjustments.
  • Mastering inhaler technique and adding lifestyle measures boosts control.
  • Never adjust or stop Dulera without medical advice.
  • If you're concerned about your symptoms, use Ubie's free symptom checker to better understand what you're experiencing and get guidance on next steps.
  • Always speak to your doctor about serious or life-threatening concerns.

Asthma management is a partnership. By understanding the dulera dosage for severe persistent asthma and staying engaged with your healthcare team, you can achieve the best possible control and quality of life.

(References)

  • * Hoshino M, Ohtawa J, et al. Mometasone furoate/formoterol fumarate for the treatment of asthma: a review. *Ther Clin Risk Manag*. 2010 Sep 28;6:461-71. doi: 10.2147/TCRM.S10578. PMID: 20957018.

  • * Nathan RA. Mometasone furoate/formoterol fumarate for the treatment of asthma. *Expert Rev Respir Med*. 2011 Apr;5(2):167-75. doi: 10.1586/ers.11.8. PMID: 21469850.

  • * Virchow JC, Kuna P, et al. Clinical efficacy of mometasone furoate/formoterol fumarate in patients with moderate-to-severe asthma: a systematic review. *Respir Med*. 2012 Jun;106(6):783-93. doi: 10.1016/j.rmed.2012.02.001. PMID: 22387190.

  • * Sanford M, McCormack PL. Mometasone furoate/formoterol fumarate: a review of its use in adults and adolescents with asthma. *Drugs*. 2010 Mar 12;70(4):493-519. doi: 10.2165/11204620-000000000-00000. PMID: 20230132.

  • * Wang T, Su C, et al. Safety and efficacy of mometasone furoate/formoterol fumarate fixed-dose combination in patients with asthma: a systematic review and meta-analysis. *J Asthma Allergy*. 2016 Feb 26;9:19-33. doi: 10.2147/JAA.S100259. PMID: 26973347.

Thinking about asking ChatGPT?Ask me instead

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.